2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
OwnerGilles Gosselin, Jean-Louis Imbach +3inventors
InventorsGilles Gosselin, Jean-Louis Imbach, Anne-Marie Aubertin, Jean-Pierre Sommadossi, Raymond F. Schinazi
Life of this patent
Estimating the term…
Abstract
Method for the sterospecific preparation of 2′ or 3′ deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleoside compounds. 2′ or 3′ deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleoside compounds are also described. Finally, the invention concerns the use of these compounds, and particularly 2′, 3′ dideoxy-β-L-fluorocytidine, as drugs, and especially as anti-viral agents.
Claims16
Method for the preparation of 2′- or 3′-deoxy-and 2′,3′-dideoxy-β-L-pentofuranocucleoside compounds of formula I:
- 6
- in which
- B represents a purine or pyrimidine base;
- R1 represents OH;
- R2 and R3 represent, independently of each other, H or OH;
- at least one of R2 and R3 represents H;
- characterized in that the following steps are carried out:
- 1) a compound of formula (II) is condensed with the base B in order to obtain the compound of formula (III) according to the scheme
- 7
- in which formulae (II) and (III)
- R′1 and R′2 have the meanings given for R1 and R2 except that when R1 and R2 represent OH, the said OH group is protected by a protecting group such as an acyl, benzoyl, benzyl or silyl group,
- R′3 represents a C1 to C5 alkyl group or a phenyl radical, which are optionally substituted,
- X is a leaving group such as Cl, Br, I or a C1 to C5 acyloxy or alkoxy group,
- B′ is a purine or pyrimidine base B which is optionally appropriately protected, p2 2) the R′3 CO group at the 2′ position is removed by deacetylation so as to obtain an OH group and a
- compound of formula
- 8
- 3) optionally, the OH group at the 2′ position is removed;
- and
- 4) where appropriate, the R′1 and R′2 groups and the B′ base are deprotected so as to obtain the compounds of formula (I).
Stereoisomeric 2′,3′-dideoxy-β-L-pentofuranonucleoside compounds corresponding to the formula (I)
- 11
- in which:
- R1 represents OH
- R2 and R3 represent H and
- B represents uracil, guanine, hypoxanthine, b fluorocytosine, fluorocytosine.
Dependencies are inferred from the claim text.